Berlin/Hamburg/Cologne/Munich, September 2025 – In recent weeks, YPOG has advised on a wide range of transactions in the startup sector. Among others, we have collaborated with renowned investors and companies such as Haufe Group Ventures, Simon Capital, Vorwerk Ventures, EIC Fund, Forgent and Adesso Ventures.
YPOG advises Haufe Group Ventures and Simon Capital on investment in SQUAKE
Hamburg, August 28, 2025 – YPOG has advised Haufe Group Ventures as well as existing investor Simon Capital on an investment in the Berlin-based climate tech startup SQUAKE. The investment highlights the growing importance of CO₂ transparency and practical solutions for business travel and supply chains.
Based in Berlin, SQUAKE has developed a platform that enables companies to precisely calculate, document in compliance with regulations, and offset CO₂ emissions across business travel and supply chains with certified measures. Companies such as Siemens, Airbnb and DB Schenker are already relying on SQUAKE’s approach to make sustainability practicable within complex processes.
With the new funding, SQUAKE aims to further advance the development of its technology and address the rising ESG requirements, particularly in the SME sector. A key focus lies on Scope 3 emissions, which arise indirectly from business travel, supply chains or services and account for more than half of the total carbon footprint in many industries.
Team
Dr. Adrian Haase (Lead, Transactions), Partner, Hamburg
Dr. Gerrit Breetholt (Transactions), Associate, Hamburg
YPOG advises Simon Capital on seed financing round of Vox AI
Hamburg, August 29, 2025 – YPOG has advised Simon Capital on an investment in the Dutch startup Vox AI. The Amsterdam-based company has raised 7.5 Mio. EUR in a seed financing round. With this investment, Simon Capital supports the further development of a technology that has the potential to fundamentally transform operations in the quick-service restaurant industry. The round was led by global venture capital firm Headline.
Founded in 2023 and headquartered in Amsterdam, Vox AI develops a conversational voice AI platform specifically designed for drive-thru and automation solutions in quick-service restaurants. The technology enables customers to place orders at drive-thrus and via mobile apps fully autonomously, while also supporting employees with real-time alerts and shift guidance. The company thus addresses key challenges of the global quick-service restaurant market, including labour shortages, high turnover, increasing wage pressure and growing operational complexity.
With the new capital, Vox AI plans to accelerate its international expansion, including the opening of a new office in San Francisco. According to the company, the solution already increases return on investment by up to 17 times, shortens queues, boosts customer satisfaction and allows employees to focus on more meaningful tasks.
Team
Dr. Adrian Haase (Lead, Transactions), Partner, Hamburg
Tobias Lovett (Transactions), Associated Partner, Berlin
YPOG advises Vorwerk Ventures on pre-seed financing round of Aiomics
Hamburg, September 5, 2025 – YPOG has advised Vorwerk Ventures on the pre-seed financing round of Berlin-based healthtech startup Aiomics, in which the company raised EUR 2 million. Alongside Vorwerk Ventures, Calm/Storm, Norrsken Evolve, Rule30 as well as several business angels also participated.
Aiomics is developing an AI-powered documentation platform designed to relieve medical professionals from time-consuming administrative work. The solution processes speech, handwriting, and documents in a single validated workflow, ensures completeness and consistency through a final clinical review, and transfers structured, coded data back into existing systems. This reduces errors, accelerates reimbursements, and allows medical staff to spend more time with patients.
With its technology, Aiomics addresses one of the most pressing challenges in the European healthcare system: workforce shortages exacerbated by excessive documentation requirements. Unlike pure transcription solutions, the platform ensures that patient data is reviewed, structured, and processed in a legally compliant and audit-proof manner. With the fresh capital, the startup plans to further develop its solution, scale into diverse care settings, and prepare for expansion into additional European markets.
Team
Dr. Adrian Haase (Lead, Transactions), Partner, Hamburg
Miriam Peer (Transactions), Associate, Hamburg
Dr. Lutz Schreiber (IP/IT/Data Protection), Partner, Hamburg
Dr. Florian Wittner (IP/IT/Data Protection), Associate, Hamburg
YPOG advises EIC Fund on 16 million EUR Series A financing round of Bioweg
Hamburg/Cologne, September 18, 2025 – YPOG has advised the European Innovation Council (EIC Fund), an initiative of the European Commission, on the 16 million EUR Series A financing round of the Lower Saxony-based biotech startup Bioweg. The round was led by the French Axeleo Capital Green Tech Industry Fund. Further investors, besides the EIC Fund, include NBank Capital, BonVenture and seed investor Dr.-Ing. Frank Jenner.
Bioweg develops bio-based and biodegradable alternatives to fossil-based polymers, which are still used in the form of microplastics in numerous products. By leveraging bacterial fermentation and green chemistry, the company creates functional ingredients for applications in cosmetics, personal and home care, pharmaceuticals, and agriculture. The production process makes use of side streams from the food industry and enables a sustainable, scalable solution for markets increasingly affected by regulation.
With the new funding, Bioweg plans to build an industrial-scale production facility in Germany and accelerate its market entry in Europe. The company currently operates a pilot plant at its Quakenbrück site as well as a material science and application laboratory in Monheim. Over the coming years, production will be scaled up to industrial volumes in order to supply industry customers and support their transition to microplastic-free products.
YPOG has supported the EIC Fund for many years with regular advice on investments in German startups.
Team
Dr. Adrian Haase (Co-Lead, Transactions), Partner, Hamburg
Dr. Johannes Janning (Co-Lead Transactions), Partner, Cologne
Laura Franke (Transactions), Senior Project Lawyer, Cologne
Janic Salcedas (Transactions), Associate, Cologne
YPOG advises Forgent on pre-seed financing round
Berlin, September 24, 2025 – YPOG advised Forgent on a pre-seed financing round of EUR 4.3 million. The round was led by Cherry Ventures; additional participants include Charlie Songhurst, Katrin Suder, and experts associated with OpenAI, Anthropic, and DeepMind.
Forgent develops an AI-powered platform that helps companies find public tenders faster, assess fit with precision, and prepare error-free bids. The solution searches fragmented procurement portals, checks formal requirements, and supports the creation of competitive proposals, significantly reducing time and costs.
With the new capital, Forgent plans to expand its team, enter additional industries, and further develop its AI technology. The goal is to increase the match rate for suitable tenders and improve win rates in procurement procedures.
Team
Dr. Benjamin Ullrich (Lead, Transactions), Partner, Berlin
Tobias Lovett (Transactions), Associated Partner, Berlin
Jörg Schrade (Tax), Partner, Munich
Dr. Benedikt Flöter (IP/IT/Data Protection), Partner, Berlin
Theresia Heinrich (Transactions), Senior Associate, Hamburg
Farina Weber (Transactions), Associate, Berlin
Ninetta Kleindienst (Tax), Associate, Munich
YPOG advises Adesso Ventures on Optimeleon’s pre-seed financing round
Hamburg, September 26, 2025 – YPOG advised Adesso Ventures on the pre-seed financing of Berlin-based startup Optimeleon totaling 1.5 million EUR. The round was led by Caesar Ventures and Adesso Ventures. Additional investors include Felix Jahn (Home24, McMakler), Valentin Dushe (Vergleich.org) and Artjem Weissbeck (Kapten & Son), alongside other tech and marketing experts.
Optimeleon develops an AI-based platform that automates conversion rate optimisation for websites. Its own multi-agent AI analyses site structure and content, generates tailored variants for target segments, and serves the best-performing version in real time. This enables companies to optimise their web pages dynamically and with significantly less effort. Compared to traditional A/B testing, marketing teams achieve results around five times faster, usually within a few weeks.
With the new capital, Optimeleon plans to further develop its product and accelerate its go-to-market in the DACH region, establishing AI-driven conversion optimisation more broadly among growth-focused companies.
Team
Dr. Adrian Haase (Lead, Transactions), Partner, Hamburg
Miriam Peer (Transactions), Associate, Hamburg